Verisk Analytics (NASDAQ: VRSK) CFO sells 400 shares under 10b5-1 plan

Rhea-AI Filing Summary

Verisk Analytics Chief Financial Officer Elizabeth Mann reported an open-market sale of 400 shares of common stock on March 17, 2026 at an average price of $204.71 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan she entered into on December 11, 2025.

Following this sale, Mann directly holds 20,384 shares of Verisk Analytics common stock. The filing reflects a relatively small, pre-planned disposition by a senior executive while maintaining a substantial remaining equity stake.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mann Elizabeth

(Last) (First) (Middle)

C/O VERISK ANALYTICS, INC.

545 WASHINGTON BOULEVARD

(Street)

JERSEY CITY NEW JERSEY 07310

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Verisk Analytics, Inc. [ VRSK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/17/2026		S		400(1)	D	$204.71	20,384	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan that Ms. Mann entered into on December 11, 2025.

	/s/ Kathy Card Beckles, Attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider trade did Verisk Analytics (VRSK) disclose for CFO Elizabeth Mann?

Verisk Analytics disclosed that CFO Elizabeth Mann sold 400 shares of common stock. The shares were sold in an open-market transaction at an average price of $204.71 per share on March 17, 2026, according to a Form 4 filing.

Was the Verisk (VRSK) CFO stock sale made under a 10b5-1 trading plan?

Yes, the CFO’s sale was made under a Rule 10b5-1 trading plan. The filing states the 400-share sale occurred pursuant to a 10b5-1 plan that Elizabeth Mann entered into on December 11, 2025, indicating the transaction was pre-planned.

How many Verisk (VRSK) shares did the CFO sell and at what price?

The Verisk CFO sold 400 shares of common stock at $204.71 per share. The Form 4 identifies this as an open-market sale on March 17, 2026, with the price reported as the average transaction price for the shares sold.

How many Verisk Analytics (VRSK) shares does CFO Elizabeth Mann hold after the sale?

After the reported sale, CFO Elizabeth Mann directly holds 20,384 Verisk shares. The Form 4 specifies this post-transaction ownership figure, showing her remaining direct stake in Verisk Analytics common stock following the 400-share disposition.

What type of insider transaction was reported in Verisk (VRSK) CFO’s Form 4?

The filing reports an open-market sale of common stock by the CFO. The transaction is coded “S” on the Form 4, described as a sale in an open market or private transaction, involving 400 non-derivative shares of Verisk Analytics common stock.

Does the Verisk (VRSK) Form 4 show any option exercises or derivative trades by the CFO?

No derivative transactions are listed in this Form 4 for the CFO. The filing’s transaction details and derivativeSummary section reflect only a single non-derivative open-market sale of 400 common shares, with no option exercises or other derivative activity reported.